Nomura Holdings
SVNT

Nomura Holdings’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Nomura Holdings’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-81,300
Closed -$52K – 2636
2013
Q3 		$52K Buy
81,300
+2,800
+4% +$1.79K ﹤0.01% 2127
2013
Q2 		$47K Buy
+78,500
New +$54.7K ﹤0.01% 2078

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $172M AUM 21.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Nomura Holdings's SVNT Position: Q4 2013 in Review

Nomura Holdings sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 81,300 shares — an estimated $52K sold.

Nomura Holdings first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $52K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Nomura Holdings reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Nomura Holdings sold 81,300 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $52K.
  • Nomura Holdings first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Nomura Holdings's SAVIENT PHARMACEUTICALS INC position peaked at $52K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Nomura Holdings's 13F filing for Q4 2013, filed 14 Feb 2014.